Has antiproliferative effect on human colon adenocarcinoma cells.

Has high affinity for peripheral (Type A) receptors.

Very potent in inhibiting proliferation & inducing differentiation of myeloid leukemic cells in vitro.

Drug under development for treatment of metabolic diseases.

A highly lipophilic aromatic retinoid with antiproliferative and sebum supressive effects.

PAF antagonist.

Desacetylcefotaxime linked by a carbamate bond at the 3' position to ciprofloxacin.